跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 93 条关于
“QN-139b”
全部
93
临床试验
21
药物
60
机构
1
资讯
11
去年
First-in-Human iPSC-CAR-NK Cell Therapy Shows Promise for Autoimmune Disease Treatment
去年
Qualigen Therapeutics Secures Global Patent Protection for Cancer Drug QN-302 Across 25+ Countries
去年
Qnovia's RespiRx Inhaler Receives FDA Clearance for Smoking Cessation Trial
2年前
Qualigen Therapeutics Announces Public Offering to Advance Cancer Programs
去年
Qualigen Therapeutics Secures $4.5 Million in Series A-3 Preferred Stock Financing to Advance Cancer Therapeutics Pipeline
去年
Qnovia Doses First Patient in Phase 1 Trial of RespiRx™ Nicotine Inhaler for Smoking Cessation
去年
Qihan Biotech Receives FDA Clearance for QT-019B, First Universal Dual-Target CAR-T Therapy for Refractory Lupus
去年
Qihan Biotech Unveils Novel Cytokine Pathway Engineering for Enhanced CAR-T Therapy Without Lymphodepletion
9个月前
Zura Bio Advances Tibulizumab Phase 2 Trials with $139 Million Cash Runway Through 2027
5个月前
Vivani Medical Advances NPM-139 Semaglutide Implant Toward Phase 1 Trial Following Successful Preclinical Data
第 1 页,共 2 页
上一页
下一页